Saracatinib
![Saracatinib Structure](CAS/GIF/379231-04-6.gif)
- CAS No.
- 379231-04-6
- Chemical Name:
- Saracatinib
- Synonyms
- CS-69;EOS-61866;saracatinib;Gemcabene Calcium;Saracatinib, >=98%;AZD0530 difuMarate;AZD0530(Saracatinib);Saracatinib (AZD0530);Saracatinib USP/EP/BP;TIANFUCHEM-- Saracatinib
- CBNumber:
- CB61518531
- Molecular Formula:
- C27H32ClN5O5
- Molecular Weight:
- 542.03
- MOL File:
- 379231-04-6.mol
- MSDS File:
- SDS
- Modify Date:
- 2023/6/30 15:45:59
Melting point | 84-89°C |
---|---|
Boiling point | 671.2±55.0 °C(Predicted) |
Density | 1.348 |
storage temp. | -20°C |
solubility | Soluble in DMSO (50 mg/ml) and ethanol (54 mg/mL with warming) |
form | solid |
pka | 7.55±0.10(Predicted) |
color | White |
Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months. |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|
Signal word | Warning | |||||||||
Hazard statements | H317-H319 | |||||||||
Precautionary statements | P280-P305+P351+P338 | |||||||||
NFPA 704 |
|
Saracatinib Chemical Properties,Uses,Production
Description
Saracatinib is a dual inhibitor of the tyrosine kinases c-
Chemical Properties
White Solid
Saracatinib Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 182)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
Capot Chemical Co.,Ltd. | 571-85586718 +8613336195806 | China | 29798 | 60 | Inquiry |
Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | China | 21668 | 55 | Inquiry |
ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | China | 32760 | 60 | Inquiry |
BOC Sciences | +1-631-485-4226 | United States | 19553 | 58 | Inquiry |
CONIER CHEM AND PHARMA LIMITED | +8618523575427 | China | 49391 | 58 | Inquiry |
Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 | China | 24330 | 58 | Inquiry |
AFINE CHEMICALS LIMITED | +86-0571-85134551 | China | 15395 | 58 | Inquiry |
Sinoway Industrial co., ltd. | 0592-5800732; +8613806035118 | China | 990 | 58 | Inquiry |
379231-04-6(Saracatinib)Related Search:
chevron_left
1of4
chevron_right
7-[2-[4-Methylpiperazin-1-yl]ethoxy]-5-[[tetrahydropyran-4-yl]oxy]-4-[[6-chloro-2,3-Methylenedioxyphenyl]aMino]quinazoline
(S)-2-(4-(4-chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetaMide
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine Saracatinib (AZD0530)
Saracatinib N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine
Saracatinib, >=98%
Gemcabene Calcium
saracatinib
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine
4-(6-Chloro-2,3-methylenedioxyanilino)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-tetrahydropyran-4-yloxyquinazoline
4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methyl-1-piperazinyl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)-
N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine
N-(5-Chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine
Saracatinib (AZD0530)
AZD0530(Saracatinib)
AZD0530 difuMarate
N-(5-Chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyr
CS-69
AZD0530; AZD-0530; AZD 0530
EOS-61866
Saracatinib USP/EP/BP
TIANFUCHEM-- Saracatinib
Saracatinib AZD0530 AZD-0530
N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine
379231-04-6
C27H32ClN5O5
Aromatics
Heterocycles
Intermediates & Fine Chemicals
Pharmaceuticals
Protein Kinase Inhibitors and Activators
APIs
Inhibitors